TCR2 Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board – Markets Insider
|
TCR2 Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board
Markets Insider Dr. Grupp is a world-renowned pediatric oncologist and cancer researcher who delivered chimeric antigen receptor (CAR) T cell therapy to the first pediatric patient in the world and paved the clinical development path for engineered T cell therapies … |
